Teyi Pharmaceutical Group (002728.SZ) has accumulated a repurchase of 2.48% of shares, costing 93.9418 million yuan.

03/03/2025

Te Yi Pharmaceutical (002728.SZ) announced that as of February 28, 2025, the company will be traded through centralized bidding...

Teyi Pharmaceutical Group (002728.SZ) announced that as of February 28, 2025, the company repurchased 12.7296 million shares of its own stock through centralized bidding, representing 2.48% of the company's current total share capital. The total amount paid was RMB 93.9418 million (excluding related transaction costs).

Shougang Langze (02553) has published a supplementary prospectus, expecting to be listed on July 15th.

HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.

Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.

Shougang Langze (02553) has published a supplementary prospectus, expecting to be listed on July 15th.

HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.

Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.